{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T12:21:36Z","timestamp":1788524496139,"version":"build-2803163510"},"reference-count":121,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Thyroid cancer (TC) and colorectal cancer are common malignancies of the endocrine and gastrointestinal systems, respectively, and continue to impose a substantial global disease burden. The tumor immune microenvironment (TIME) plays a central role in tumor initiation, progression, and therapeutic response; however, the cellular composition and intercellular communication networks within the TIME exhibit marked heterogeneity between these two malignancies. Recent advances in single-cell sequencing and spatial transcriptomics have revealed complex and dynamic alterations in immune cell subsets, stromal cell functions, cytokine networks, and metabolic programs within the TIME. In particular, bidirectional communication between tumor cells and immune cells has emerged as a critical determinant of immune evasion and therapeutic resistance. Nevertheless, most existing studies have focused on individual tumor types, and systematic comparisons of the shared and distinct features of the TIME in thyroid cancer and colorectal cancer remain limited. Moreover, combination therapeutic strategies targeting the TIME are still under active investigation. This review systematically compares the immune microenvironments of thyroid cancer (TC) and colorectal cancer (CRC), highlighting the development of more precise and effective immunotherapeutic strategies for thyroid cancer and colorectal cancer.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1916192","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T12:07:27Z","timestamp":1788523647000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The tumor immune microenvironment of thyroid cancer and colorectal cancer: cellular crosstalk and therapeutic implications"],"prefix":"10.3389","volume":"17","author":[{"given":"Guangzhe","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Thyroid Surgery, First Hospital of China Medical University","place":["Shenyang, Liaoning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengzhong","family":"Xing","sequence":"additional","affiliation":[{"name":"Department of Anus and Intestine Surgery, First Affiliated Hospital of China Medical University","place":["Shenyang, Liaoning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuehua","family":"Gong","sequence":"additional","affiliation":[{"name":"Tumor Etiology and Screening Department of Cancer Institute and General Surgery, The First Hospital of China Medical University","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.929091","article-title":"What is the status of immunotherapy in thyroid neoplasms","volume":"13","author":"Garcia-Alvarez","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00082","article-title":"Metabolic reprogramming in thyroid carcinoma","volume":"8","author":"Coelho","year":"2018","journal-title":"Front Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13206119","article-title":"Aggressive types of Malignant thyroid neoplasms","volume":"13","author":"Boudina","year":"2024","journal-title":"J Clin Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2018.0655","article-title":"Microsatellite instability occurs in a subset of follicular thyroid cancers","volume":"29","author":"Genutis","year":"2019","journal-title":"Thyroid"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-018-1663-8","article-title":"Association between CTLA-4\u2009+\u200949A\u2009>\u2009G and -\u2009318C\u2009>\u2009T single-nucleotide polymorphisms and susceptibility to thyroid neoplasm","volume":"62","author":"Abtahi","year":"2018","journal-title":"Endocrine"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-025-02380-2","article-title":"TGF-\u03b2 builds a dual immune barrier in colorectal cancer by impairing T cell recruitment and instructing immunosuppressive SPP1(+) macrophages","volume":"57","author":"Henriques","year":"2025","journal-title":"Nat Genet"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1699500","article-title":"New insights into the tumor immune microenvironment and immunotherapy of thyroid cancer","volume":"17","author":"Du","year":"2026","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3803\/enm.2023.1802","article-title":"Metabolic reprogramming in thyroid cancer","volume":"39","author":"Ju","year":"2024","journal-title":"Endocrinol Metab (Seoul)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2017.11.009","article-title":"AKT activity is elevated in aggressive thyroid neoplasms where it promotes proliferation and invasion","volume":"103","author":"Matson","year":"2017","journal-title":"Exp Mol Pathol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"31024","DOI":"10.1038\/s41598-025-16674-2","article-title":"SRCIN1 promotes thyroid carcinoma growth by activating Wnt signaling pathway","volume":"15","author":"Han","year":"2025","journal-title":"Sci Rep"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.102043","article-title":"A spatially resolved transcriptome landscape during thyroid cancer progression","volume":"6","author":"Liao","year":"2025","journal-title":"Cell Rep Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41419-024-06598-6","article-title":"Integrating spatial and single-cell transcriptomics reveals tumor heterogeneity and intercellular networks in colorectal cancer","volume":"15","author":"Xiao","year":"2024","journal-title":"Cell Death Dis"},{"key":"B13","doi-asserted-by":"publisher","first-page":"130","DOI":"10.21203\/rs.3.rs-2721118\/v1","article-title":"Single-cell transcriptomic analysis revealed the tumor-associated microenvironment of papillary thyroid carcinoma with metastasis","volume":"29","author":"Zhang","year":"2025","journal-title":"Oncol Lett"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1186\/s12967-024-05963-5","article-title":"Unraveling the interplay of CD8\u2009+\u2009T cells and microRNA signaling in cancer: implications for immune dysfunction and therapeutic approaches","volume":"22","author":"Zabeti Touchaei","year":"2024","journal-title":"J Transl Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"20576","DOI":"10.1038\/s41598-025-06241-0","article-title":"Single-cell transcriptomics analysis reveals a disrupted NK-T cell interaction network in liver metastatic cancer","volume":"15","author":"Wang","year":"2025","journal-title":"Sci Rep"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.labinv.2025.104213","article-title":"Integrating tumor intraepithelial CD8(+) and stromal FOXP3(+) T-cell densities as an enhanced immune prognostic index in colorectal cancer","volume":"105","author":"Tuomisto","year":"2025","journal-title":"Lab Invest"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1293618","article-title":"Location matters: spatial dynamics of tumor-infiltrating T cell subsets is prognostic in colon cancer","volume":"15","author":"Zhu","year":"2024","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.15482","article-title":"The role of FOXK2-FBXO32 in breast cancer tumorigenesis: Insights into ribosome-associated pathways","volume":"16","author":"Liao","year":"2025","journal-title":"Thorac Cancer"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/s41417-023-00663-6","article-title":"Integrative single-cell transcriptome analysis reveals immune suppressive landscape in the anaplastic thyroid cancer","volume":"30","author":"Feng","year":"2023","journal-title":"Cancer Gene Ther"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1184167","article-title":"Integration of single-cell RNA sequencing and bulk RNA transcriptome sequencing reveals a heterogeneous immune landscape and pivotal cell subpopulations associated with colorectal cancer prognosis","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17213527","article-title":"Comparative oncology: cross-sectional single-cell transcriptomic profiling of the tumor microenvironment across seven human cancers","volume":"17","author":"Okamoto","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1186\/s12967-025-07307-3","article-title":"Fibroblast activation protein (FAP)-mediated promotion of metastasis via the FN1-TGF\u03b2 axis and immune suppression in aggressive thyroid cancer","volume":"23","author":"Udinotti","year":"2025","journal-title":"J Transl Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.934221","article-title":"Development and validation of a cancer-associated fibroblast-derived lncRNA signature for predicting clinical outcomes in colorectal cancer","volume":"13","author":"Pan","year":"2022","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216985","article-title":"Colorectal cancer-associated fibroblasts inhibit effector T cells via NECTIN2 signaling","volume":"595","author":"Agorku","year":"2024","journal-title":"Cancer Lett"},{"key":"B25","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12967-025-06103-3","article-title":"Single-cell and spatial-resolved profiling reveals cancer-associated fibroblast heterogeneity in colorectal cancer metabolic subtypes","volume":"23","author":"Wang","year":"2025","journal-title":"J Transl Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2023.0427","article-title":"Macrophage-induced carboxypeptidase A4 promotes the progression of anaplastic thyroid cancer","volume":"34","author":"Choi","year":"2024","journal-title":"Thyroid"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s44319-024-00186-7","article-title":"ZEB1-mediated fibroblast polarization controls inflammation and sensitivity to immunotherapy in colorectal cancer","volume":"25","author":"Menche","year":"2024","journal-title":"EMBO Rep"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.173712","article-title":"A distinct tumor microenvironment makes anaplastic thyroid cancer more lethal but immunotherapy sensitive than papillary thyroid cancer","volume":"9","author":"Han","year":"2024","journal-title":"JCI Insight"},{"key":"B29","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s41419-025-08009-w","article-title":"Cancer-associated fibroblasts expressing FSTL3 promote vasculogenic mimicry formation and drive colon cancer Malignancy","volume":"16","author":"Ying","year":"2025","journal-title":"Cell Death Dis"},{"key":"B30","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s12943-024-02180-y","article-title":"THBS2\u2009+\u2009cancer-associated fibroblasts promote EMT leading to oxaliplatin resistance via COL8A1-mediated PI3K\/AKT activation in colorectal cancer","volume":"23","author":"Zhou","year":"2024","journal-title":"Mol Cancer"},{"key":"B31","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41698-025-00924-7","article-title":"Comprehensive single-cell RNA analysis reveals intertumoral microenvironment heterogeneity and hub niche of carcinogenesis in thyroid cancer","volume":"9","author":"Xu","year":"2025","journal-title":"NPJ Precis Oncol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70373","article-title":"Pan-cancer single-cell transcriptomic analysis reveals divergent expression of embryonic proangiogenesis gene modules in tumorigenesis","volume":"13","author":"Wang","year":"2024","journal-title":"Cancer Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgac548","article-title":"Targeting tumor hypoxia inhibits aggressive phenotype of dedifferentiated thyroid cancer","volume":"108","author":"Ma","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-025-00883-y","article-title":"Tumor-associated endothelial cells in tumor immune escape and immunotherapy: multifaceted roles and treatment approaches","volume":"14","author":"Zheng","year":"2025","journal-title":"biomark Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-025-03297-8","article-title":"Extracellular matrix stiffness regulates colorectal cancer progression via HSF4","volume":"44","author":"Wang","year":"2025","journal-title":"J Exp Clin Cancer Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.19628","article-title":"Insights into the molecular mechanisms underlying the function of lysyl oxidase like 1 in cancers","volume":"13","author":"Wang","year":"2025","journal-title":"PeerJ"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2022.113159","article-title":"Hypoxia promotes thyroid cancer progression through HIF1\u03b1\/FGF11 feedback loop","volume":"416","author":"Chen","year":"2022","journal-title":"Exp Cell Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-5868429\/v1","article-title":"HIF-1\u03b1 integrates lipogenic FASN and glycolytic GLUT3 to overcome intratumor oxidative and hypoxic stress for colorectal cancer metastasis","volume":"45","author":"Wang","year":"2026","journal-title":"Oncogene"},{"key":"B39","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/s41388-025-03674-9","article-title":"Matrix stiffness-driven cytoskeletal remodeling and tumor progression in anaplastic thyroid cancer via integrin-focal adhesion kinase signaling","volume":"45","author":"Li","year":"2026","journal-title":"Oncogene"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1882956","article-title":"Nanomedicine delivery systems remodel the immunosuppressive microenvironment of colorectal cancer: synergistic strategies and mechanisms of targeted immune checkpoint inhibitors","volume":"17","author":"Zhu","year":"2026","journal-title":"Front Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2026.101842","article-title":"Elevated triggering receptor expressed on myeloid cells 2 expression in tumor-associated macrophages suppresses cytotoxic T cell infiltration and facilitates immune escape in colorectal cancer","volume":"20","author":"Liu","year":"2026","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00384-025-04852-7","article-title":"Association of lysyl oxidase expression with clinicopathological features in colorectal adenocarcinomas","volume":"40","author":"\u00c7a\u011flayan","year":"2025","journal-title":"Int J Colorectal Dis"},{"key":"B43","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1186\/s12967-024-05199-3","article-title":"Understanding the matrix: collagen modifications in tumors and their implications for immunotherapy","volume":"22","author":"Borst","year":"2024","journal-title":"J Transl Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.931647","article-title":"Role of cytotoxic T cells and PD-1 immune checkpoint pathway in papillary thyroid carcinoma","volume":"13","author":"Banerjee","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/aqac077","article-title":"PD-L1 expression in colorectal adenocarcinoma is associated with the tumor immune microenvironment and epithelial-mesenchymal transition","volume":"158","author":"Secinti","year":"2022","journal-title":"Am J Clin Pathol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-024-09822-3","article-title":"PD-L1 and B7-H3 are effective prognostic factors and potential therapeutic targets for high-risk thyroid cancer","volume":"35","author":"Zhu","year":"2024","journal-title":"Endocr Pathol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16213632","article-title":"PD-L1 expression varies in thyroid cancer types and is associated with decreased progression free survival (PFS) in patients with anaplastic thyroid cancer","volume":"16","author":"Shobab","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/cas.16136","article-title":"WTAP-induced N(6)-methyladenosine of PD-L1 blocked T-cell-mediated antitumor activity under hypoxia in colorectal cancer","volume":"115","author":"Liu","year":"2024","journal-title":"Cancer Sci"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2026.102786","article-title":"Reprogramming T cell-myeloid crosstalk overcomes immune resistance in colorectal cancer","volume":"7","author":"Mestrallet","year":"2026","journal-title":"Cell Rep Med"},{"key":"B50","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1097\/pai.0000000000001181","article-title":"Immunohistochemical expression of immune checkpoints; CTLA-4, LAG3, and TIM-3 in cancer cells and tumor-infiltrating lymphocytes (TILs) in colorectal carcinoma","volume":"32","author":"Abdelrahman","year":"2024","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12964-025-02638-6","article-title":"Targeting T cell exhaustion in colorectal cancer: emerging roles of LAG-3, TIM-3, and TIGIT signaling in overcoming immunotherapy resistance","volume":"24","author":"Zamani","year":"2026","journal-title":"Cell Commun Signal"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110207","article-title":"Co-expression of PD-1 with TIGIT or PD-1 with TIM-3 on tumor-infiltrating CD8(+) T cells showed synergistic effects on improved disease-free survival in treatment-na\u00efve CRC patients","volume":"119","author":"Meyiah","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-024-09552-y","article-title":"Regulation of PDL-1 expression in thyroid carcinoma cells by tumor cell derived cytokines activating STAT3","volume":"73","author":"Klemke","year":"2024","journal-title":"Immunol Res"},{"key":"B54","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1007\/s00262-025-04187-w","article-title":"Tumor-draining lymph nodes respond to immune checkpoint inhibition and orchestrate tumor immune remodeling","volume":"74","author":"Zhang","year":"2025","journal-title":"Cancer Immunol Immunother"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117412","article-title":"IDO1 inhibitors are synergistic with CXCL10 agonists in inhibiting colon cancer growth","volume":"179","author":"Yang","year":"2024","journal-title":"BioMed Pharmacother"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.21203\/rs.3.rs-1501746\/v1","article-title":"Indoleamine 2,3-dioxygenase 2 immunohistochemical expression in medullary thyroid carcinoma: implications in prognosis and immunomodulatory effects","volume":"22","author":"Gu","year":"2022","journal-title":"BMC Cancer"},{"key":"B57","doi-asserted-by":"publisher","first-page":"4251","DOI":"10.1038\/s41467-023-39953-w","article-title":"IL1R1(+) cancer-associated fibroblasts drive tumor development and immunosuppression in colorectal cancer","volume":"14","author":"Koncina","year":"2023","journal-title":"Nat Commun"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20184413","article-title":"Immune and inflammatory cells in thyroid cancer microenvironment","volume":"20","author":"Ferrari","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1438235","article-title":"Immune microenvironment in papillary thyroid carcinoma: roles of immune cells and checkpoints in disease progression and therapeutic implications","volume":"15","author":"Zheng","year":"2024","journal-title":"Front Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1706496","article-title":"Induction of trained immunity in myeloid cells and their progenitors from thyroid cancer patients","volume":"16","author":"van Houten","year":"2025","journal-title":"Front Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1002\/cbin.11631","article-title":"miR-4443 targets TRIM14 to suppress metastasis and energy metabolism of papillary thyroid carcinoma (PTC) in vitro","volume":"45","author":"Zuo","year":"2021","journal-title":"Cell Biol Int"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.71766","article-title":"Integrative single-cell and machine learning analysis identifies an EMT-associated prognostic signature for papillary thyroid cancer","volume":"15","author":"Xu","year":"2026","journal-title":"Cancer Med"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v16.i5.1690","article-title":"Mechanisms of myeloid-derived suppressor cell-mediated immunosuppression in colorectal cancer and related therapies","volume":"16","author":"Nie","year":"2024","journal-title":"World J Gastrointest Oncol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.advms.2021.12.005","article-title":"The effect of l-arginine supplementation and surgical trauma on the frequency of myeloid-derived suppressor cells and T lymphocytes in tumour and blood of colorectal cancer patients","volume":"67","author":"Szefel","year":"2022","journal-title":"Adv Med Sci"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncrna.2024.03.003","article-title":"ALKBH5 regulates arginase 1 expression in MDSCs and their immunosuppressive activity in tumor-bearing host","volume":"9","author":"Feng","year":"2024","journal-title":"Non-coding RNA Res"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70411","article-title":"Cholesterol 25-hydroxylase enhances myeloid-derived suppressor cell (MDSC) immunosuppression via the stimulator of interferon genes (STING)-tank-binding kinase 1 (TBK1)-receptor-interacting protein kinase 3 (RIPK3) pathway in colorectal cancer","volume":"6","author":"Zhou","year":"2025","journal-title":"MedComm (2020)"},{"key":"B67","doi-asserted-by":"publisher","first-page":"31580","DOI":"10.1038\/s41598-024-75750-1","article-title":"The expression of CCL17 and potential prognostic value on tumor immunity in thyroid carcinoma based on bioinformatics analysis","volume":"14","author":"Gu","year":"2024","journal-title":"Sci Rep"},{"key":"B68","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.anl.2025.12.004","article-title":"C-C chemokine receptor 4 is a candidate for regulatory T-cell-depletion immunotherapy in differentiated thyroid cancer","volume":"53","author":"Sano","year":"2026","journal-title":"Auris Nasus Larynx"},{"key":"B69","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1158\/2767-9764.crc-23-0319","article-title":"Characterizing neutrophil subtypes in cancer using scRNA sequencing demonstrates the importance of IL1\u03b2\/CXCR2 axis in generation of metastasis-specific neutrophils","volume":"4","author":"Fetit","year":"2024","journal-title":"Cancer Res Commun"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.iliver.2022.06.002","article-title":"Caspase-6\/gasdermin C-mediated tumor cell pyroptosis promotes colorectal cancer progression through CXCL2-dependent recruitment of myeloid-derived suppressor cells","volume":"12","author":"Gao","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202513986","article-title":"Immunometabolic rewiring of dendritic cells to overcome glutamine-driven immune suppression in colorectal cancer","volume":"13","author":"Zhang","year":"2026","journal-title":"Adv Sci (Weinh)"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113702","article-title":"Emerging role of metabolic reprogramming in the immune microenvironment and immunotherapy of thyroid cancer","volume":"144","author":"Li","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1186\/s40001-024-01828-1","article-title":"Inactivation of KDM6A promotes the progression of colorectal cancer by enhancing the glycolysis","volume":"29","author":"Zhang","year":"2024","journal-title":"Eur J Med Res"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2025.167993","article-title":"Hypoxia facilitates stemness of colon cancer cells via histone lactylation","volume":"1871","author":"Zhang","year":"2025","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3366","article-title":"VSIG4 promotes tumour-associated macrophage M2 polarization and immune escape in colorectal cancer via fatty acid oxidation pathway","volume":"15","author":"Liu","year":"2025","journal-title":"Clin Transl Med"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1563303","article-title":"Impact of lactate on immune cell function in the tumor microenvironment: mechanisms and therapeutic perspectives","volume":"16","author":"Gu","year":"2025","journal-title":"Front Immunol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15245795","article-title":"Lactate-induced CCL8 in tumor-associated macrophages accelerates the progression of colorectal cancer through the CCL8\/CCR5\/mTORC1 axis","volume":"15","author":"Zhou","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-3150640\/v1","article-title":"Tumor-resident microbiota contributes to colorectal cancer liver metastasis by lactylation and immune modulation","volume":"43","author":"Gu","year":"2024","journal-title":"Oncogene"},{"key":"B79","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/s41746-025-01927-1","article-title":"Developing a thyroid cancer differentiation state classification system using deep residual networks and metabolic signature profiling","volume":"8","author":"Zhang","year":"2025","journal-title":"NPJ Digit Med"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1111\/cas.70057","article-title":"Epacadostat overcomes cetuximab resistance in colorectal cancer by targeting IDO-mediated tryptophan metabolism","volume":"116","author":"Zhou","year":"2025","journal-title":"Cancer Sci"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.101900","article-title":"ARID5A stabilizes indoleamine 2,3-dioxygenase expression and enhances CAR T cell exhaustion in colorectal cancer","volume":"42","author":"Wu","year":"2024","journal-title":"Transl Oncol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.871792","article-title":"Indoleamine 2,3-dioxygenase immune status as a potential biomarker of radioiodine efficacy for advanced distant metastatic differentiated thyroid cancer","volume":"12","author":"Shi","year":"2022","journal-title":"Front Oncol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1002\/path.6415","article-title":"A Tc1- and Th1-T-lymphocyte-rich tumor microenvironment is a hallmark of MSI colorectal cancer","volume":"266","author":"Huang","year":"2025","journal-title":"J Pathol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.104108","article-title":"Efficacy of pembrolizumab in microsatellite-stable, tumor mutational burden-high metastatic colorectal cancer: genomic signatures and clinical outcomes","volume":"10","author":"Yamaguchi","year":"2025","journal-title":"ESMO Open"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.2340\/1651-226x.2024.26452","article-title":"Neurotrophic tyrosine receptor kinase gene fusions in adult and pediatric patients with solid tumors: a clinicogenomic biobank and record linkage study of expression frequency and patient characteristics from Finland","volume":"63","author":"Zhang","year":"2024","journal-title":"Acta Oncol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2026.102776","article-title":"A tumor-intrinsic WNT-inhibitory NOTUM program drives immune resistance in microsatellite stable colorectal cancer","volume":"7","author":"Chua","year":"2026","journal-title":"Cell Rep Med"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1002\/cjp2.304","article-title":"Validation of the prognostic value of CD3 and CD8 cell densities analogous to the Immunoscore\u00ae by stage and location of colorectal cancer: an independent patient cohort study","volume":"9","author":"Alwers","year":"2023","journal-title":"J Pathol Clin Res"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.34657","article-title":"Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 KEYNOTE-158 study","volume":"129","author":"Oh","year":"2023","journal-title":"Cancer"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.113826","article-title":"The genomic and evolutionary landscapes of anaplastic thyroid carcinoma","volume":"43","author":"Zeng","year":"2024","journal-title":"Cell Rep"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae271","article-title":"Genomic landscape and clinical features of advanced thyroid carcinoma: a national database study in Japan","volume":"109","author":"Toda","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2402141","article-title":"Nivolumab plus ipilimumab in microsatellite-instability-high metastatic colorectal cancer","volume":"391","author":"Andre","year":"2024","journal-title":"N Engl J Med"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1136\/jcp-2025-210585","article-title":"Myeloid-derived suppressor cells in anaplastic thyroid carcinoma: insights from prospective immune profiling and implications for targeted immunotherapy","volume":"79","author":"Boruah","year":"2026","journal-title":"J Clin Pathol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2026.168303","article-title":"HN1\/CEBPB\/CCL2 signaling shapes VSIG4(+) tumor-associated macrophages in anaplastic thyroid carcinoma","volume":"1872","author":"Fang","year":"2026","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-023-00691-z","article-title":"Sirp\u03b1 on tumor-associated myeloid cells restrains antitumor immunity in colorectal cancer independent of its interaction with CD47","volume":"5","author":"Huang","year":"2024","journal-title":"Nat Cancer"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2022.166591","article-title":"IL2RA(+)VSIG4(+) tumor-associated macrophage is a key subpopulation of the immunosuppressive microenvironment in anaplastic thyroid cancer","volume":"1869","author":"Pan","year":"2023","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-023-03549-6","article-title":"Tumor-associated macrophages as a potential therapeutic target in thyroid cancers","volume":"72","author":"Zhu","year":"2023","journal-title":"Cancer Immunol Immunother"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.cir-24-1194","article-title":"USP15 facilitates colorectal cancer immune evasion through SMYD3\/CCL2-dependent myeloid-derived suppressor cell recruitment","volume":"13","author":"Han","year":"2025","journal-title":"Cancer Immunol Res"},{"key":"B98","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41590-024-02068-5","article-title":"The lactate receptor HCAR1 drives the recruitment of immunosuppressive PMN-MDSCs in colorectal cancer","volume":"26","author":"He","year":"2025","journal-title":"Nat Immunol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/5867047","article-title":"Vascular normalization was associated with colorectal tumor regression upon anti-PD-L1 combinational therapy","volume":"2023","author":"Zhang","year":"2023","journal-title":"J Immunol Res"},{"key":"B100","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3892\/ol.2025.15287","article-title":"Efficacy and safety of fruquintinib combined with immunotherapy in later-line treatment of metastatic colorectal cancer","volume":"30","author":"Peng","year":"2025","journal-title":"Oncol Lett"},{"key":"B101","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1186\/s12951-024-02584-4","article-title":"Targeting CSF1R in myeloid-derived suppressor cells: insights into its immunomodulatory functions in colorectal cancer and therapeutic implications","volume":"22","author":"Tong","year":"2024","journal-title":"J Nanobiotechnol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107126","article-title":"CSF1R inhibition reprograms tumor-associated macrophages to potentiate anti-PD-1 therapy efficacy against colorectal cancer","volume":"202","author":"Lv","year":"2024","journal-title":"Pharmacol Res"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.4c00264","article-title":"Lipopolysaccharide induces resistance to CAR-T cell therapy of colorectal cancer cells through TGF-\u03b2-mediated stemness enhancement","volume":"22","author":"Tao","year":"2025","journal-title":"Mol Pharm"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1002\/mc.23882","article-title":"Hypoxia promotes Malignant progression of colorectal cancer by inducing POSTN(+) cancer-associated fibroblast formation","volume":"64","author":"Qin","year":"2025","journal-title":"Mol Carcinog"},{"key":"B105","doi-asserted-by":"publisher","first-page":"29","DOI":"10.25259\/cytojournal_245_2024","article-title":"Enhanced efficacy of dual chimeric antigen receptor-T cells targeting programmed death-ligand 1 and cancer-associated fibroblasts in colorectal cancer in vitro","volume":"22","author":"Gao","year":"2025","journal-title":"Cytojournal"},{"key":"B106","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12967-023-04829-6","article-title":"DNTGF-\u03b2R armored CAR-T cell therapy against tumors from bench to bedside","volume":"22","author":"Wang","year":"2024","journal-title":"J Transl Med"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaf639","article-title":"Tumor-infiltrating T lymphocytes recognize thyroid-specific proteins and neo-antigens in follicular cell-derived thyroid cancers","volume":"111","author":"Garza","year":"2026","journal-title":"J Clin Endocrinol Metab"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202306364","article-title":"Dynamics of the \u0393\u03b4tcr repertoires during the dedifferentiation process and pilot implications for immunotherapy of thyroid cancer","volume":"11","author":"Hao","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol30030200","article-title":"Tumor-infiltrating immune cell landscapes in the lymph node metastasis of papillary thyroid cancer","volume":"30","author":"Amanullah","year":"2023","journal-title":"Curr Oncol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1177\/10507256251372191","article-title":"Immunotherapy in initial treatment of anaplastic thyroid cancer: evaluation of overall survival in a national cancer database study","volume":"35","author":"Kini","year":"2025","journal-title":"Thyroid"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-03-0698","article-title":"Dendritic cell vaccination in medullary thyroid carcinoma","volume":"10","author":"Stift","year":"2004","journal-title":"Clin Cancer Res"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105374","article-title":"Dendritic cell vaccine therapy for colorectal cancer","volume":"164","author":"Wooster","year":"2021","journal-title":"Pharmacol Res"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1154818","article-title":"Tubeimuside I improves the efficacy of a therapeutic Fusobacterium nucleatum dendritic cell-based vaccine against colorectal cancer","volume":"14","author":"Tong","year":"2023","journal-title":"Front Immunol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13090960","article-title":"Case report: a multi-peptide vaccine targeting individual somatic mutations induces tumor infiltration of neoantigen-specific T cells in a patient with metastatic colorectal cancer","volume":"13","author":"Rabsteyn","year":"2025","journal-title":"Vaccines (Basel)"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115659","article-title":"Integration of metabolomics and transcriptomics reveals metformin suppresses thyroid cancer progression via inhibiting glycolysis and restraining DNA replication","volume":"168","author":"Ouyang","year":"2023","journal-title":"BioMed Pharmacother"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-22-3042","article-title":"Metformin reprograms tryptophan metabolism to stimulate CD8+ T-cell function in colorectal cancer","volume":"83","author":"Huang","year":"2023","journal-title":"Cancer Res"},{"key":"B117","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/s41420-024-01970-z","article-title":"Neutrophil diversity is associated with T-cell immunity and clinical relevance in patients with thyroid cancer","volume":"10","author":"Lee","year":"2024","journal-title":"Cell Death Discov"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1662464","article-title":"Metabolic reprogramming and immunosenescence in colorectal cancer: mechanisms and therapeutic implications","volume":"13","author":"Zhu","year":"2025","journal-title":"Front Cell Dev Biol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14184442","article-title":"Preclinical evaluation of novel tyrosine-kinase inhibitors in medullary thyroid cancer","volume":"14","author":"Saronni","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B120","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s00262-025-04241-7","article-title":"Immunomodulatory effects of lenvatinib in patients with advanced thyroid cancer","volume":"75","author":"Changoer","year":"2025","journal-title":"Cancer Immunol Immunother"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.05.002","article-title":"A multicenter, open-label, randomized, phase II study of cediranib with or without lenalidomide in iodine 131-refractory differentiated thyroid cancer","volume":"34","author":"Rosenberg","year":"2023","journal-title":"Ann Oncol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1916192\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T12:07:28Z","timestamp":1788523648000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1916192\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":121,"alternative-id":["10.3389\/fimmu.2026.1916192"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1916192","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,4]]},"article-number":"1916192"}}